03-23-2011 06:10 PM CET - Science & Education
Print PDF Email

GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development

Press release from: Onyx Scientific Ltd
GMP synthesis chemistry service organisation
GMP synthesis chemistry service organisation
Leading chemistry services organisation, Onyx Scientific Ltd, is pleased to announce an increased demand for its early-phase, GMP synthesis, Investigational New Drug (IND) services for the development of Active Pharmaceutical Ingredients (APIs).

“At Onyx we plan for success by focussing on detail” explains CEO Tony Flinn. “Our service driven systems deliver comprehensive chemical route development, efficient raw materials sourcing, thorough analysis and world-class solid-state characterization. We are recognised as the leading GMP synthesis provider and are increasingly viewed as THE company to support the development of value for money INDs”.

Dr Daryl Rees, Chief Executive, Salupont Consulting comments, "Having worked with Onyx Scientific for many years, I can say they are one of the finest suppliers in the marketplace. They have delivered a range of different services both on time and on budget, without hidden costs. Their GMP offering has been of particular use to us and we continually find that Onyx delivers excellent value for money".

An equally valued client adds, “I don't think there’s another team I’ve worked with who respond so quickly and flexibly to the regulators, and to my many questions. All data generated is of the highest quality. My many calls are met with good humour, practicality, pragmatism and a lot of patience. It's genuinely rare to work with a partner who demonstrates such a high degree of commitment. Reagents were ordered ahead of me asking, Onyx worked late, missed holiday leave and ran experiments over the weekend. The service they provide is above and beyond anything I'd have expected and it has made my job here so much easier”.

Good manufacturing practice (GMP) compliance is an international requirement for the manufacture of medicinal products for human and veterinary use. Compliance ensures medicinal products are produced safely and correctly. GMP Synthesis is the term commonly associated with manufacturing for Clinical Phases 1 to 3.

In addition to GMP synthesis and scale up, Onyx Scientific’s breath of services include solid-form polymorph screening, salt selection, custom synthesis, process development and lead optimization. Visit: www.onyx-scientific.com

Leading global GMP chemistry services organisation

Onyx Scientific Limited
Silverbriar
Enterprise Park East
Sunderland
SR5 2TQ
United Kingdom
Tel: +44 (0) 191 516 6516
www.onyx-scientific.com
suejones@onyx-scientific.com

This release was published on openPR.
News-ID: 167864
del.icio.us:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education MisterWong:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education Digg:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education StumbleUpon:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education Technorati:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education Reddit:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education Furl:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education WebNews:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education OneView:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education LinkArena:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education YiGG:GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development - Pressreleases - openPR - Science & Education
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.